The worldwide dash to get goods to the U.S. ahead of President Trump's tariffs has been distorting trade patterns all year. Ireland's pharma-export boom is a striking example. The small European ...

All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced ...

Johnson & Johnson has announced a significant construction programme as part of a voluntary agreement with the Trump Administration, committing billions of dollars to build new pharmaceutical ...

Tourmaline went public in 2023 via a reverse merger with the struggling cell therapy developer Talaris. The deal gave Tourmaline funds to develop pacibekitug, an antibody that targets interleukin-6, a ...